We only have this paper's title and publication details.
Read it at the sourceThese results suggest that serum LRG-1 is a promising biomarker for pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Furukawa et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: